Dolby Laboratories, Inc. annual report, FY2022

Dolby Laboratories, Inc. — FY2022 Form 10-K

Reporting period: Fiscal year ended September 30, 2022 (a 53-week year); comparison is with the 52-week fiscal year ended September 24, 2021. This is an annual filing, not a standalone fourth-quarter report. Dolby develops and licenses audio and imaging technologies; licensing generated 93% of FY2022 revenue.

Key financial results

MetricFY2022FY2021Change
Total revenue$1,253.8 million$1,281.3 millionDown 2%
Licensing revenue$1,164.5 million$1,214.1 millionDown 4%
Products and services revenue$89.3 million$67.1 millionUp 33%
Gross margin$1,112.4 million; 88.7% of revenue$1,151.2 million; 89.8%Down $38.8 million
Operating income$206.6 million$344.4 millionDown 40%
Net income attributable to Dolby$184.1 million$310.2 millionDown 41%
Diluted EPS$1.81$2.97Down 39%
Operating cash flow$318.6 million$447.8 millionDown $129.2 million

Operating margin was approximately 16.5%, versus 26.9% in FY2021. Higher operating expenses, including a $34.4 million Intertrust settlement and increased sales and marketing costs, contributed to lower operating income; FY2021 also included a $13.9 million gain on sale of property. The effective tax rate rose to 14.6% from 10.3%.

Liquidity, capital allocation and balance sheet

  • At September 30, 2022, cash and cash equivalents were $620.1 million, short- and long-term investments totaled $291.7 million, and working capital was $1.03 billion. Cash and cash equivalents were $1.23 billion at the prior year-end.
  • Current assets were $1.31 billion and current liabilities $277.5 million. The company reported no borrowings or other financial debt on the balance sheet; operating lease liabilities totaled $50.9 million, including current and non-current amounts.
  • FY2022 financing cash outflows included $530.5 million of share repurchases and $100.1 million of dividends. Management stated available liquidity and operating cash flows should meet anticipated requirements for at least the next 12 months.
  • Net cash used in investing activities was $295.9 million, including $38.2 million for business combinations, primarily Millicast, and increased purchases of marketable securities.

Material changes and management commentary

  • Licensing weakness reflected lower broadcast revenue, including lower TV shipments and recoveries, and lower mobile revenue due partly to timing. Consumer electronics and PC licensing revenue increased, while products and services benefited from cinema market recovery and Dolby.io-related activity.
  • International markets generated 63% of revenue, down from 67% in FY2021. China accounted for 20% of revenue. One customer represented 10% of FY2022 revenue.
  • Dolby reported more than 280 open Dolby Cinema sites and more than 7,000 Dolby Atmos screens installed or committed. Cinema-related revenue improved with reopening and stronger box office, but remained exposed to capacity limits and recovery uncertainty.
  • Dolby acquired Millicast for $38.8 million in January 2022 to support interactive streaming through Dolby.io. Management described Dolby.io as an early-stage business and said its timing and potential to become a material revenue source were uncertain.
  • No quantified revenue or earnings guidance is provided in the filing. Management expects foundational audio revenue generally to reflect device shipment trends; newer offerings depend more on adoption, licensees and content availability. The filing identifies FY2023 tax changes, including R&D capitalization requirements and foreign tax credit rules, as potentially materially adverse to future tax provisions unless postponed or modified.

Risks, contingencies and unusual items

  • Management cited inflation, higher interest rates, reduced discretionary spending, supply-chain and semiconductor constraints, COVID-19 effects, and geopolitical uncertainty as risks to licensee shipments, product launches and cinema demand.
  • Licensing depends on third-party shipment reports and estimates; revenue can fluctuate with estimate true-ups and recoveries for prior-period or unauthorized use. Recoveries are recurring but unpredictable.
  • Patent expirations, unauthorized use, enforcement challenges in some countries, royalty pricing pressure, competing technologies and changing industry standards may constrain licensing revenue. Dolby noted that revenue from older DD technologies has declined and is expected to continue declining.
  • The company recorded $34.4 million in FY2022 for the Intertrust matter, reflecting a settlement payment and an immaterial accrual; Dolby said it believed the payment resolved all related claims. Other proceedings were not expected by management to have a material adverse effect, though outcomes remain uncertain.
  • Other exposures include $69.7 million of unrecognized tax benefits, contractual indemnification obligations whose maximum exposure cannot be estimated, and $206.0 million of disclosed contractual commitments, including naming rights and purchase obligations.
  • The Dolby family and affiliates held 85.7% of combined voting power at year-end through the dual-class structure. This gives them substantial control over matters requiring stockholder approval.

Important facts for investors to verify

  • Whether FY2022 licensing softness and lower recoveries persist, especially in broadcast and mobile, and how royalty estimate adjustments compare with actual reports.
  • Whether cinema demand, box office receipts and equipment availability continue to recover, and whether Dolby.io adoption can develop into material revenue.
  • The impact of FY2023 tax-law changes on the effective tax rate and cash taxes.
  • How much of the decline in operating cash and total liquidity reflects ongoing repurchases, dividends, investment purchases and operating performance.
  • Developments in patent enforcement, licensing disputes, tax examinations and any remaining consequences of the Intertrust settlement.